Dennis S. Charney

Affiliations: 
Neurosciences Icahn School of Medicine at Mount Sinai, New York, NY, United States 
Area:
Neuroscience Biology, Mental Health, Clinical Psychology
Google:
"Dennis Charney"
Mean distance: 19.29
 
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Paranjpe I, Russak A, De Freitas JK, et al. (2020) Clinical Characteristics of Hospitalized Covid-19 Patients in New York City. Medrxiv : the Preprint Server For Health Sciences
Krystal JH, Charney DS, Duman RS. (2020) A New Rapid-Acting Antidepressant. Cell. 181: 7
Morris LS, Tan A, Smith DA, et al. (2020) Sub-millimeter variation in human locus coeruleus is associated with dimensional measures of psychopathology: An in vivo ultra-high field 7-Tesla MRI study. Neuroimage. Clinical. 25: 102148
Morris LS, Costi S, Tan A, et al. (2020) Ketamine normalizes subgenual cingulate cortex hyper-activity in depression. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
Hoch MM, Doucet GE, Moser DA, et al. (2019) Initial Evidence for Brain Plasticity Following a Digital Therapeutic Intervention for Depression. Chronic Stress (Thousand Oaks, Calif.). 3: 2470547019877880
Feder A, Fred-Torres S, Southwick SM, et al. (2019) The Biology of Human Resilience: Opportunities for Enhancing Resilience Across the Life Span. Biological Psychiatry. 86: 443-453
Jha MK, Qamar A, Vaduganathan M, et al. (2019) Screening and Management of Depression in Patients With Cardiovascular Disease: JACC State-of-the-Art Review. Journal of the American College of Cardiology. 73: 1827-1845
Costi S, Soleimani L, Glasgow A, et al. (2019) Lithium continuation therapy following ketamine in patients with treatment resistant unipolar depression: a randomized controlled trial. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology
Krystal JH, Abdallah CG, Sanacora G, et al. (2019) Ketamine: A Paradigm Shift for Depression Research and Treatment. Neuron. 101: 774-778
Guo W, Machado-Vieira R, Mathew S, et al. (2019) Correction: Exploratory genome-wide association analysis of response to ketamine and a polygenic analysis of response to scopolamine in depression. Translational Psychiatry. 9: 108
See more...